Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of Type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 15, Issue 11, 2013, Pages 929-934

  Lin, Maria H ^a   Connor, Crystal G ^b   Ruedy, Katrina J ^b   Beck, Roy W ^b   Kollman, Craig ^b   Buckingham, Bruce ^c   Redondo, Maria J ^d   Schatz, Desmond ^e   Haro, Heidi ^f   Lee, Joyce M ^g,h   Tamborlane, William V ⁱ   Wood, Jamie R ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f Children's Hospital Colorado   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; CAUCASIAN; CHILD; FEMALE; HEALTH INSURANCE; HUMAN; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; JUVENILE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROPORTIONAL HAZARDS MODEL; RACE; SCHOOL CHILD; SOCIAL STATUS; SOCIOECONOMICS;

ADOLESCENT; AGE FACTORS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEDICALLY UNINSURED; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84887120438     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0132     Document Type: Article

References (17)

1. Renner R, Pfü tzner A, Trautmann M, Harzer O, Sauter K, Landgraf R: Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. Diabetes Care 1999;22:784-788.
2. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 1996;19:324-327.
3. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-1146.
4. Mü ller-Godeffroy E, Treichel S, Wagner VM; German Working Group for Paediatric Pump Therapy: Investigation of quality of life and family burden issues during insulin pump therapy in children with type 1 diabetes mellitus-a large-scale multicentre pilot study. Diabet Med 2009;26: 493-501.
5. Willi SM, Planton J, Egede L, Schwarz S: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003;143:796-801.
6. Pinhas-Hamiel O, Tzadok M, Hirsh G, Boyko V, Graph-Barel C, Lerner-Geva L, Reichman B: The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control. Diabetes Technol Ther 2010;12:567-573.
7. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M: Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010;27:339-347.
8. Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL: Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic b-cell function in type 1 diabetes. Diabetes Technol Ther 2011;13:1023-1030.
9. Sulli N, Shashaj B: Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med 2006;23:900-906.
10. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605.
11. Lin MH, Kaminski B, Wood JR; Pediatric Diabetes Consortium: Race and socioeconomic status are independent predictors of youth receiving insulin pump therapy in the first year of type 1 diabetes treatment [abstract O/5/FRI/07]. Pediatr Diabetes 2011;12(Suppl S15):14-39.
12. Lin MH, Wood JR, Wong-Jacobson S; Pediatric Diabetes Consortium: Race and socioeconomic status independently predict whether youth receive insulin pump therapy in the first year of type 1 diabetes treatment [abstract 1253-P]. Diabetes 2012;61(Suppl 1):A324.
13. Wood JR, Lin MH, Connor C, Ruedy K, Beck R, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee J, Tamborlane W; Pediatric Diabetes Consortium: Race and socioeconomic status are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes [abstract O-70]. Diabetes Technol Ther 2013;15(Suppl 1):A25.
14. Pediatric Diabetes Consortium: The Pediatric Diabetes Consortium: improving care of children with type 1 diabetes through collaborative research. Diabetes Technol Ther 2010; 12:685-688.
15. Ramchandani N, Ten S, Anhalt H, Sinha S, Ching J, Finkelstein A, Maclaren N: Insulin pump therapy from the time of diagnosis of type 1 diabetes. Diabetes Technol Ther 2006; 8:663-670.
16. Paris CA, Imperatore G, Klingensmith G, Petitti D, Rodriguez B, Anderson AM, Schwartz ID, Standiford DA, Pihoker C: Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2009;155:183-189.
17. Edmonds-Myles S, Tamborlane WV, Grey M: Perception of the impact of type 1 diabetes on low-income families. Diabetes Educ 2010;36:318-325.